Category
blog
-
2023
-
ChemDiv has created a unique TM KATO platform
-
ChemDiv has created a unique TM KATO platform
-
Endo buy out long-time partner biopharma
-
Endo buy out long-time partner biopharma
-
Endo buy out long-time partner biopharma
-
Astellas received a positive conclusion from CHMP
-
Astellas received a positive conclusion from CHMP
-
Astellas received a positive conclusion from CHMP
-
ESTEVE и KOWA Pharmaceuticals America
-
ESTEVE и KOWA Pharmaceuticals America